Point of Care Test of LTA Level in Tear Fluid, Measured With a POCT Test, in DE Patients Following IPL Treatment

This study focuses on understanding how Intense Pulsed Light (IPL) treatment can help people with dry eye disease, particularly those caused by Meibomian gland dysfunction (MGD), which is a common form of dry eye. Dry eye can cause symptoms like eye pain, blurry vision, and tear film problems, often due to factors like aging, menopause, or certain medications. IPL has been used for skin conditions and is now being explored as a treatment for dry eye, potentially helping by reducing inflammation and improving tear quality. This study is important as it aims to evaluate the effectiveness of IPL in treating dry eye by looking at levels of a protein called Lymphotoxin-alpha (LTA) in tears, which might be a marker for dry eye severity and treatment response. In the study, participants with dry eye will receive IPL treatment. Researchers will collect tear samples to measure levels of LTA before and after the IPL sessions, using a special test designed to be quick and easy to use. This will help to see if the treatment affects the amount of LTA, providing insight into how IPL might help reduce dry eye symptoms. The study does not list specific risks or benefits but aims to provide clearer evidence for using IPL as a treatment option, potentially offering a more practical approach for managing dry eye in clinical settings.